Ian Fletcher Kent
Président chez Pulmagen Therapeutics LLP
Profil
Ian Fletcher Kent is the founder of Ardana Plc.
He currently serves as the Chairman of Pulmagen Therapeutics LLP.
He previously served as the Non-Executive Chairman of Piramed Ltd., Regenerative Medicine Assets Ltd., Intercytex Ltd., RiboTargets Ltd., and Acacia Pharma Ltd.
He was also the Chairman of Cambridge Drug Discovery Holdings Ltd., Adprotech Ltd., LGC Group Holdings Ltd., Pulmagen Therapeutics (Synergy) Ltd., Etiologics Ltd., Innovata Ltd., and Avantium NV.
Additionally, he served as the Non-Executive Director of Ligand UK Ltd., Charles River Discovery Research Services UK Ltd., and LGC (Holdings) Ltd.
He was the Agrochemical Director of Boots Group Plc and the Technical Director of Dalgety Plc.
Postes actifs de Ian Fletcher Kent
| Sociétés | Poste | Début |
|---|---|---|
Pulmagen Therapeutics LLP
 Pulmagen Therapeutics LLP Pharmaceuticals: MajorHealth Technology Pulmagen Therapeutics Ltd. manufactures and develops respiratory drugs. Its services include pulmagen respiratory product pipeline, pulmagen crth2 antagonist product pipeline, new generation bronchodilators-astrazeneca collaboration, theocort-inhaled corticosteroid re-sensitisation, inhaled ppar gamma agonists and chiesi collaboration-anti-inflammatory agents. The company was founded in February 2010 and is headquartered in Slough, the United Kingdom. | Président | 06/09/2011 |
Anciens postes connus de Ian Fletcher Kent
| Sociétés | Poste | Fin |
|---|---|---|
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Président | 31/12/2015 |
| ACACIA PHARMA GROUP PLC | Président | 31/12/2015 |
Ardana Plc
 Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Fondateur | 27/06/2007 |
Boots Group Plc
 Boots Group Plc Pharmaceuticals: MajorHealth Technology Boots Group Plc retails chemists' merchandise and auto parts; provision of opticians' and other healthcare services; development, manufacture and marketing of healthcare and consumer products | Corporate Officer/Principal | - |
| Dalgety Plc | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AVANTIUM N.V. | Producer Manufacturing |
| Entreprise privées | 19 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Charles River Discovery Research Services UK Ltd.
 Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Commercial Services |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Commercial Services |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Health Technology |
Regenerative Medicine Assets Ltd.
 Regenerative Medicine Assets Ltd. Pharmaceuticals: MajorHealth Technology Regenerative Medicine Assets Ltd. engaged in the healthcare business. The company was founded by Paul Kemp in 2000 and was headquartered in Bristol, the United Kingdom. | Health Technology |
Boots Group Plc
Boots Group Plc Pharmaceuticals: MajorHealth Technology Boots Group Plc retails chemists' merchandise and auto parts; provision of opticians' and other healthcare services; development, manufacture and marketing of healthcare and consumer products | Health Technology |
| Dalgety Plc | Consumer Non-Durables |
LGC (Holdings) Ltd.
 LGC (Holdings) Ltd. Miscellaneous Commercial ServicesCommercial Services LGC Holdings Ltd. provides chemical, DNA and other scientific analysis in areas such as drug development, health care services, chemicals & petrochemicals, law enforcement, agriculture, food production, and environmental quality & maintenance. The company was founded in February 1996 and is located in Teddington, UK. | Commercial Services |
Intercytex Ltd.
 Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Health Technology |
Cambridge Drug Discovery Holdings Ltd.
 Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne. | Commercial Services |
| RiboTargets Ltd. | Health Technology |
Adprotech Ltd.
 Adprotech Ltd. Pharmaceuticals: MajorHealth Technology Part of Interfor Corp., Adprotech Ltd. is a British pharmaceutical manufacturing company. The company is based in Royston, UK. Adprotech was acquired by EACOM Timber Corp., part of Interfor Corp. from November 23, 2021 on April 20, 2004 for $15.23 million. | Health Technology |
LGC Group Holdings Ltd.
 LGC Group Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services LGC Group Holdings, Ltd. provides pharmaceutical research and laboratory services. It offers chemical analysis and diagnostic services for the public and private sectors. The company was founded in 1996 and is headquartered in Teddington, the United Kingdom. | Commercial Services |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
| Etiologics Ltd. | Commercial Services |
Innovata Ltd.
 Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Pulmagen Therapeutics LLP
Pulmagen Therapeutics LLP Pharmaceuticals: MajorHealth Technology Pulmagen Therapeutics Ltd. manufactures and develops respiratory drugs. Its services include pulmagen respiratory product pipeline, pulmagen crth2 antagonist product pipeline, new generation bronchodilators-astrazeneca collaboration, theocort-inhaled corticosteroid re-sensitisation, inhaled ppar gamma agonists and chiesi collaboration-anti-inflammatory agents. The company was founded in February 2010 and is headquartered in Slough, the United Kingdom. | Health Technology |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: OtherHealth Technology Acacia Pharma Group Plc is a holding company, which engages in the development and commercialization of pharmaceutical product. It focuses on the new nausea and vomiting treatments for surgical and cancer patients. The company was founded by Julian Clive Gilbert, Robert William Gristwood, and Andrew Muncey in 2007 and is headquartered in Duxford, the United Kingdom. | Health Technology |